{"id":17713,"date":"2021-04-08T07:45:48","date_gmt":"2021-04-08T07:45:48","guid":{"rendered":"https:\/\/www.wholecelium.com\/?p=17713"},"modified":"2023-05-11T09:50:50","modified_gmt":"2023-05-11T07:50:50","slug":"maps-celebrates-its-35th-anniversary","status":"publish","type":"post","link":"https:\/\/staging.wholecelium.com\/lv\/blog\/kartes-atzime-35-gadadienu\/","title":{"rendered":"MAPS svin 35 gadu jubileju"},"content":{"rendered":"

N\u0113, jaunie las\u012bt\u0101ji! \u0160is nav \u0123eogr\u0101fijas blogs! MAPS noz\u012bm\u0113 Daudznozaru Psihod\u0113lisko p\u0113t\u012bjumu asoci\u0101cija<\/a>. <\/em>Un ikvienam, kur\u0161 ir iesaist\u012bjies vai pat tikai interes\u0113jas par psihed\u0113lisk\u0101s medic\u012bnas att\u012bst\u012bbu, ir par ko vi\u0146iem pateikties. Liel\u0101k\u0101 da\u013ca noz\u012bm\u012bgu p\u0113t\u012bjumu par to, k\u0101 psihed\u0113li\u0137i (s\u0101kot no MDMA, psilocib\u012bns<\/a>, iboga\u012bns<\/a> LSD un ayahuasca).<\/em> var izmantot medic\u012bn\u0101, ietver MAPS iesaist\u012b\u0161anu.\u00a0<\/strong><\/p>\n\n\n\n

T\u0101 k\u0101 \u0161\u012b gada 8. apr\u012bl\u012b MAPS svin\u0113s 35 gadu jubileju, m\u0113s nol\u0113m\u0101m izr\u0101d\u012bt cie\u0146u, izsekojot bezpe\u013c\u0146as organiz\u0101cijas laika l\u012bnijai no pietic\u012bgiem pirms\u0101kumiem l\u012bdz sp\u0113c\u012bgajam psihod\u0113lisko l\u012bdzek\u013cu aizst\u0101vim, k\u0101ds tas ir \u0161odien! <\/p>\n\n\n\n

Kas ir MAPS?<\/em><\/h2>\n\n\n\n

Vispirms par to, k\u0101 darbojas MAPS pa\u0161i<\/em> aprakst\u012bt savu organiz\u0101ciju? Riks Doblins<\/a>MAPS dibin\u0101t\u0101js skaidro \u0161\u0101di;<\/p>\n\n\n\n

\"MAPS misija ir veikt zin\u0101tniskus p\u0113t\u012bjumus par psihed\u0113lisk\u0101m viel\u0101m un marihu\u0101nu un to terapeitisko potenci\u0101lu, lai t\u0101s att\u012bst\u012btu par leg\u0101liem recep\u0161u medikamentiem. Liela da\u013ca m\u016bsu darba ir m\u0113\u0123in\u0101jumi izstr\u0101d\u0101t p\u0113t\u012bjumus, sa\u0146emt at\u013cauju p\u0113t\u012bjumu veik\u0161anai, piesaist\u012bt p\u0113t\u012bjumiem naudu un p\u0113c tam tos veikt.\"<\/em><\/p>\n\n\n\n

Tas, ka MAPS nesniedz pe\u013c\u0146u t\u0101s dibin\u0101t\u0101jiem, k\u0101 ar\u012b tas, ka t\u0101 turpina darboties, saskaroties ar juridisko birokr\u0101tiju un sabiedr\u012bbas, kas indoktrin\u0113ta baid\u012bties no psihod\u0113lisk\u0101m narkotik\u0101m, neuztic\u012bbu, liecina par patiesu neatlaid\u012bbu un tic\u012bbu savai misijai. Doblins turpina;<\/p>\n\n\n\n

\"...m\u016bsu pla\u0161\u0101k\u0101 misija ir god\u012bgi izgl\u012btot sabiedr\u012bbu par \u0161o narkotiku riskiem un ieguvumiem un izveidot psihed\u0113lisko kl\u012bniku t\u012bklu, kur\u0101 \u0161\u012bs vielas patie\u0161\u0101m tiktu lietotas pacientiem.\"\" <\/em><\/p>\n\n\n\n

\"\"<\/a>\n
Riks Doblins, doktors, MAPS dibin\u0101t\u0101js<\/em><\/mark><\/figcaption>\n<\/figure>\n\n\n\n

\"Kar\u0161 pret narkotik\u0101m s\u0101kas<\/em><\/h2>\n\n\n\n

Teor\u0113tiski tas ir c\u0113ls uzdevums un piln\u012bgi bezr\u016bp\u012bgs risin\u0101jums. Ta\u010du, k\u0101 m\u0113s labi zin\u0101m, 1971. gad\u0101 s\u0101ktais smagn\u0113jais \"kar\u0161 pret narkotik\u0101m\", kas, cik m\u0113s zin\u0101m, aptur\u0113ja topo\u0161o psihod\u0113lisk\u0101s medic\u012bnas kust\u012bbu, kas, cik m\u0113s zin\u0101m, bija var\u0113tu<\/em> jau b\u016btu licis mums dz\u012bvot k\u0101d\u0101 utopij\u0101. Tas, protams, rad\u012bja izmis\u012bgu vajadz\u012bbu p\u0113c t\u0101das organiz\u0101cijas k\u0101 MAPS, lai turpin\u0101tu ies\u0101kto psihed\u0113lisko p\u0113t\u012bjumu jom\u0101. 1971. gad\u0101, kad varasiest\u0101des bija iesl\u0113gu\u0161as psihed\u0113lisko vielu pasauli, 17 gadus vecais amerik\u0101nis Riks Doblins (Rick Doblin) pirmo reizi nok\u013cuva LSD ce\u013cojum\u0101, un tas notika nejau\u0161i. Atkl\u0101jot, ka tas vi\u0146am pied\u0101v\u0101ja \"...sava veida gar\u012bga saikne un manu emociju padzi\u013cin\u0101\u0161an\u0101s\"<\/em> - vi\u0146\u0161 var\u0113ja skaidri saskat\u012bt at\u0161\u0137ir\u012bbu starp to, ko vi\u0146am st\u0101st\u012bja vald\u012bba, un to, ko psihod\u0113li\u0137i faktiski <\/em>bija. . <\/em><\/p>\n\n\n\n

MAPS, lai aizsarg\u0101tu MDMA<\/em><\/h2>\n\n\n\n

MAPS dibin\u0101\u0161anas katalizators bija MDMA kriminaliz\u0101cija. Redzot, ka \u0161\u012b viela ar augstu terapeitisko potenci\u0101lu dr\u012bzum\u0101 dosies citu psihed\u0113lisko vielu ce\u013cu, Doblins nodibin\u0101ja organiz\u0101ciju ar nosaukumu Earth Metabolic Design, lai sadarbotos ar p\u0113c iesp\u0113jas vair\u0101k zin\u0101tniekiem un psihiatriem un ieg\u016btu MDMA atbalsto\u0161u p\u0113t\u012bjumu un rezult\u0101tu b\u0101zi. Kad MDMA vai <\/em>1984. gad\u0101 MDMA k\u013cuva neleg\u0101ls, Doblins un citi ies\u016bdz\u0113ja DEA ties\u0101, lai aptur\u0113tu piln\u012bgu MDMA kriminaliz\u0101ciju, \u013caujot to izmantot k\u0101 terapeitisku l\u012bdzekli. Par laimi, vi\u0146i uzvar\u0113ja. Tom\u0113r sekoja v\u0113l daudzas tiesas pr\u0101vas un tiesas s\u0113des, un galu gal\u0101 DEA diem\u017e\u0113l pan\u0101ca savu. T\u0101d\u0113j\u0101di 1986. gad\u0101 Doblins izveidoja MAPS, s\u0101kotn\u0113ji, lai aizsarg\u0101tu MDMA, un 2011. gad\u0101 Doblins pazi\u0146oja; <\/p>\n\n\n\n

\"...MAPS tika uzs\u0101kta, rea\u0123\u0113jot uz to, ka \u0161is bija br\u012bnumaini daudzsolo\u0161s medikaments, kas patie\u0161\u0101m var\u0113tu iev\u0113rojami pal\u012bdz\u0113t cilv\u0113kiem, bet ar pa\u0161reiz\u0113jo soci\u0101lo strukt\u016bru nebija iesp\u0113jams virz\u012bties uz priek\u0161u.\"<\/em><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

Pan\u0101kumu laika grafiks<\/em><\/h2>\n\n\n\n

Tom\u0113r dr\u012bz vien MAPS iesaist\u012bj\u0101s visu veidu psihed\u0113lisko vielu ar terapeitisku potenci\u0101lu p\u0113tniec\u012bb\u0101. Doblinam un vi\u0146a l\u012bdzgaitniekiem 35 gadi ir biju\u0161i trausli, ta\u010du aizraujo\u0161i, un, neraugoties uz vis\u0101m gr\u016bt\u012bb\u0101m, ir g\u016bti milz\u012bgi pan\u0101kumi, un vislab\u0101kais veids, k\u0101 izp\u0113t\u012bt vi\u0146u pan\u0101kumus, ir vi\u0146u pan\u0101kumu laika grafiks. S\u0101kot ar MAPS dibin\u0101\u0161anu 1986. gad\u0101 un beidzot ar iepriek\u0161 neiedom\u0101jamu sasniegumu - FDA apstiprin\u0101juma ieg\u016b\u0161anu III f\u0101zes p\u0113t\u012bjuma veik\u0161anai par MDMA lieto\u0161anu PTSS \u0101rst\u0113\u0161anai - \u0161eit ir da\u017ei no sasniegumiem, kurus MAPS atcer\u0113sies \u0161ogad, atz\u012bm\u0113jot savu 35. gadadienu:<\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

1986<\/em><\/h3>\n\n\n\n

Riks Doblins nodibin\u0101ja Daudznozaru Psihod\u0113lisko p\u0113t\u012bjumu asoci\u0101cija <\/em>k\u0101 ofici\u0101la bezpe\u013c\u0146as p\u0113tniec\u012bbas organiz\u0101cija 1986. gada 8. apr\u012bl\u012b. Doblins pirmo reizi ies\u016bdz DEA ties\u0101. <\/p>\n\n\n\n

1987<\/em><\/h3>\n\n\n\n

MAPS sadarbojas ar D\u017eona Hopkinsa universit\u0101tes p\u0113tniekiem, izstr\u0101d\u0101jot p\u0113t\u012bjuma protokolu.<\/p>\n\n\n\n

1988<\/em><\/h3>\n\n\n\n

Doblins public\u0113 MAPS bi\u013cetena pirmo numuru. T\u0101 nosaukums ir \"MDMA var k\u013c\u016bt par leg\u0101lu medikamentu.\" <\/em>MAPS iesniedz otru MDMA p\u0113t\u012bjuma protokolu, ko FDA noraida. <\/p>\n\n\n\n

1989<\/em><\/h3>\n\n\n\n

MAPS turpin\u0101ja public\u0113t inform\u0101ciju par MDMA p\u0113t\u012bjumiem, ziedojumu piepras\u012bjumiem un ar dz\u012bvniekiem veiktu psihed\u0113lisko p\u0113t\u012bjumu p\u0101rtrauk\u0161anu. Public\u0113ts p\u0113t\u012bjums par neiroendokr\u012bno un garast\u0101vok\u013ca reakciju uz intravenozi ievad\u012btu L-triptof\u0101nu person\u0101m, kas lietoju\u0161as MDMA. <\/p>\n\n\n\n

1990<\/em><\/h3>\n\n\n\n

FDA izveido iest\u0101di, kas p\u0101rrauga psihed\u0113lisko p\u0113t\u012bjumu konvencijas, S\u0101kot veidot telpu m\u016bsdienu psihed\u0113lisk\u0101s zin\u0101tnes att\u012bst\u012bbai. MAPS r\u012bko pirmo lielo psihed\u0113lisko vielu konferenci ar nosaukumu Regul\u0113jums vai aizliegums: Psihed\u0113li\u0137i 90. gados<\/em>.<\/p>\n\n\n\n

1991<\/em><\/h3>\n\n\n\n

MAPS izdod pirmo protokolu MDMA asist\u0113tai terapijai ar v\u0113zi slimniekiem ar kl\u012bniski diagnostic\u0113tu trauksmi un depresiju. MAPS sa\u0146em $10 000 ziedojumu. Patlaban MAPS gada bud\u017eets ir maz\u0101ks par $50 000.<\/p>\n\n\n\n

1992<\/em><\/h3>\n\n\n\n

FDA ofici\u0101li at\u013cauj veikt psihed\u0113lisko vielu p\u0113t\u012bjumus ar cilv\u0113kiem. V\u0113l\u0101k t\u0101 apstiprina MAPS 1. f\u0101zes MDMA dro\u0161\u012bbas un panesam\u012bbas p\u0113t\u012bjumu k\u0101 protokolu. <\/p>\n\n\n\n

1993<\/em><\/h3>\n\n\n\n

MAPS pie\u0146em darb\u0101 savu pirmo darbinieci Silviju Taisenu. Tiek atz\u012bm\u0113ta LSD 50. gadadiena, izp\u0113t\u012btas narkotiku politikas perspekt\u012bvas un pl\u0101nots medic\u012bnisk\u0101s marihu\u0101nas izm\u0113\u0123in\u0101juma p\u0113t\u012bjums. <\/p>\n\n\n\n

1994<\/em><\/h3>\n\n\n\n

Tiek publiskoti pl\u0101ni par kl\u012bnisko marihu\u0101nas izp\u0113ti un izp\u0113t\u012bta iesp\u0113ja veikt p\u0113t\u012bjumus Izra\u0113l\u0101. Kongres\u0101 tiek pausts atbalsts marihu\u0101nas\/AIDS p\u0113t\u012bjumiem.<\/p>\n\n\n\n

1995<\/em><\/h3>\n\n\n\n

MAPS organiz\u0113 p\u0113t\u012bjumu par to, vai psihoterapija ar ketam\u012bna pal\u012bdz\u012bbu hero\u012bna atkar\u012bbas gad\u012bjum\u0101 ir efekt\u012bva. Tas notiek Krievij\u0101. Turpin\u0101s darbs pie MDMA asist\u0113tas terapijas protokola, lai \u0101rst\u0113tu trauksmi m\u016b\u017ea nogal\u0113. <\/p>\n\n\n\n

1996<\/em><\/h3>\n\n\n\n

MAPS pabeidz pirmo 1. f\u0101zes dro\u0161\u012bbas p\u0113t\u012bjumu ar MDMA. Kalifornij\u0101 un Arizon\u0101 tiek pie\u0146emti pirmie medic\u012bnisk\u0101s marihu\u0101nas likumprojekti.  <\/p>\n\n\n\n

1997<\/em><\/h3>\n\n\n\n

Slepenais priek\u0161nieks: J. Stolaroff: Sarunas ar pagr\u012bdes psihed\u0113lisk\u0101s terapijas kust\u012bbas pionieri (Conversations with a Pioneer of the Underground Psychedelic Therapy Movement), kuru autors ir Myron J. Stolaroff, ir pirm\u0101 MAPS izdot\u0101 gr\u0101mata. P\u0113tniekam Donaldam Abramam tiek pie\u0161\u0137irta $1 miljona dot\u0101cija marihu\u0101nas risku izp\u0113tei. <\/p>\n\n\n\n

1998<\/em><\/h3>\n\n\n\n

P\u0113c 34 gadiem Doblins public\u0113ja p\u0113t\u012bjumu par Timotija L\u012brija Konkorda cietuma eksperimenta turpin\u0101jumu. P\u0113t\u012bjum\u0101 ieslodz\u012btajiem tika veikta psilocib\u012bna terapija, lai m\u0113\u0123in\u0101tu samazin\u0101t atk\u0101rtotu likump\u0101rk\u0101pumu skaitu. <\/p>\n\n\n\n

1999<\/em><\/h3>\n\n\n\n

MAPS uzs\u0101k pasaul\u0113 pirmo kl\u012bnisko p\u0113t\u012bjumu, lai nov\u0113rt\u0113tu MDMA asist\u0113t\u0101s psihoterapijas efektivit\u0101ti un dro\u0161\u012bbu. Tas notiek Sp\u0101nij\u0101.<\/p>\n\n\n\n

2000<\/em><\/h3>\n\n\n\n

Dr. Riks Doblins (Rick Doblin) un Dr. Maikls Mithoefers (Michael Mithoefer) tiekas, lai pl\u0101notu darbu pie MDMA\/PTSD p\u0113t\u012bjumiem ASV.Sp\u0101nijas Vesel\u012bbas ministrija akcept\u0113 pasaul\u0113 pirmo kontrol\u0113to p\u0113t\u012bjumu par MDMA terapeitisko iedarb\u012bbu. Diem\u017e\u0113l v\u0113l\u0101k tas tiek sl\u0113gts.<\/p>\n\n\n\n

2001<\/em><\/h3>\n\n\n\n

MAPS' iesniedz FDA jaun\u0101 p\u0113t\u012bjuma protokolu par MDMA terapiju PTSS \u0101rst\u0113\u0161anai. Doktors Lils Krekers iesniedz savu pirmo DEA pieteikumu marihu\u0101nas ra\u017eo\u0161anai medic\u012bniskiem p\u0113t\u012bjumiem.<\/p>\n\n\n\n

2002<\/em><\/h3>\n\n\n\n

D\u017eord\u017es Ri\u010durte public\u0113 darbu par neirotoksisko vielu (smadze\u0146u boj\u0101jums)<\/em> MDMA iedarb\u012bbu, to ievadot prim\u0101tiem, v\u0113l\u0101k atsauca z\u0101\u013cu mar\u0137\u0113\u0161anas k\u013c\u016bdas d\u0113\u013c. Tom\u0113r negat\u012bv\u0101 atspogu\u013cojuma pla\u0161sazi\u0146as l\u012bdzek\u013cos d\u0113\u013c pret MDMA p\u0113t\u012bjumu tiek v\u0113rsti jauni aizspriedumi. Politiskais spiediens aptur Sp\u0101nijas MDMA p\u0113t\u012bjumu. <\/p>\n\n\n\n

2003<\/em><\/h3>\n\n\n\n

\u017durn\u0101ls atsauc D\u017eord\u017ea Ri\u010durtes darbu par MDMA neirotoksisko ietekmi uz prim\u0101tiem. Zin\u0101tne. <\/em>MAPS bija nos\u016bt\u012bjusi \u017eurn\u0101lam vair\u0101kas v\u0113stules, un izmekl\u0113\u0161an\u0101 atkl\u0101j\u0101s, ka dati ir neder\u012bgi. T\u0101 iemesls bija k\u013c\u016bda z\u0101\u013cu mar\u0137\u0113jum\u0101.<\/p>\n\n\n\n

2004<\/em><\/h3>\n\n\n\n

MAPS sa\u0146em savu pirmo medic\u012bnisk\u0101s kvalit\u0101tes MDMA s\u016bt\u012bjumu, kas paredz\u0113ts izm\u0113\u0123in\u0101jumam ar MDMA asist\u0113tai PTSD terapijai. Vi\u0146i ar\u012b ies\u016bdz DEA par marihu\u0101nas p\u0113t\u012bjumu blo\u0137\u0113\u0161anu. <\/p>\n\n\n\n

2005<\/em><\/h3>\n\n\n\n

MAPS rokas ar MDMA asist\u0113tas PTSS terapijas protokol\u0101 \u0160veic\u0113.  <\/p>\n\n\n\n

2006<\/em><\/h3>\n\n\n\n

MAPS ir uzs\u0101cis 2. f\u0101zes kl\u012bniskos p\u0113t\u012bjumus par MDMA asist\u0113tu terapiju PTSS \u0101rst\u0113\u0161anai \u0160veic\u0113 un Izra\u0113l\u0101. Tiek public\u0113tas divas izgl\u012btojo\u0161as gr\u0101matas, un LSD t\u0113vs<\/a> Tiek svin\u0113ta Alberta Hofma\u0146a 100. dzim\u0161anas diena. <\/p>\n\n\n\n

2007<\/em><\/h3>\n\n\n\n

MAPS un Dr. P\u012bters Gasers (Dr. Peter Gasser) sper so\u013cus ce\u013c\u0101 uz 2. f\u0101zes kl\u012bnisk\u0101 p\u0113t\u012bjuma uzs\u0101k\u0161anu par LSD asist\u0113tu psihoterapiju, lai \u0101rst\u0113tu trauksmi un depresiju, kas saist\u012bta ar ne\u0101rst\u0113jamu slim\u012bbu \u0160veic\u0113.<\/p>\n\n\n\n

2008<\/em><\/h3>\n\n\n\n

LSD s\u016bt\u012bjums ierad\u0101s \u0160veic\u0113, lai veiktu p\u0113t\u012bjumu \"LSD asist\u0113ta psihoterapija trauksmei, kas saist\u012bta ar progres\u0113jo\u0161as stadijas slim\u012bb\u0101m\". CNN zi\u0146o par MDMA asist\u0113t\u0101s terapijas potenci\u0101lajiem ieguvumiem.<\/p>\n\n\n\n

2009<\/em><\/h3>\n\n\n\n

Kan\u0101das Vesel\u012bbas ministrija apstiprina protokolu p\u0113t\u012bjumam par MDMA terapiju PTSS \u0101rst\u0113\u0161anai. Tas notiek Vank\u016bver\u0101.. ASV Kongresa locek\u013ci raksta v\u0113stules, lai atbalst\u012btu Lila Krekera l\u016bgumu ra\u017eot marihu\u0101nu medic\u012bniskiem p\u0113t\u012bjumiem.<\/p>\n\n\n\n

2010<\/em><\/h3>\n\n\n\n

MAPS public\u0113 sp\u0113c\u012bgus pozit\u012bvus rezult\u0101tus no pirm\u0101 2. f\u0101zes izm\u0113\u0123in\u0101juma p\u0113t\u012bjuma par MDMA terapiju PTSS gad\u012bjum\u0101. MAPS uzs\u0101k p\u0113t\u012bjumu par iboga\u012bna lieto\u0161anu opi\u0101tu atkar\u012bbas \u0101rst\u0113\u0161an\u0101.<\/p>\n\n\n\n

2011<\/em><\/h3>\n\n\n\n

MAPS uzs\u0101k p\u0113t\u012bjumus par ayahuasca izmanto\u0161anu atkar\u012bbas \u0101rst\u0113\u0161an\u0101. $5,5 miljonus MAPS nov\u0113l Ashawna Hailey. <\/p>\n\n\n\n

2012<\/em><\/h3>\n\n\n\n

MAPS izveido Zendo projektu, lai sniegtu psihod\u0113lisko atbalstu, dro\u0161\u012bbu un izgl\u012bt\u012bbu Burning Man kopienai Black Rock City, Nevad\u0101.<\/p>\n\n\n\n

2013<\/em><\/h3>\n\n\n\n

Tiek public\u0113ti daudzsolo\u0161i rezult\u0101ti no MAPS p\u0113t\u012bjumiem par MDMA terapiju PTSD \u0101rst\u0113\u0161anai \u0160veic\u0113 un ayahuasca terapiju atkar\u012bbas \u0101rst\u0113\u0161anai. Vair\u0101k nek\u0101 1500 cilv\u0113ku no visas pasaules ierodas uz MAPS. Psihed\u0113lisk\u0101 zin\u0101tne 2013<\/em> konferenc\u0113 Oklend\u0101, Kalifornij\u0101.<\/p>\n\n\n\n

2014<\/em><\/h3>\n\n\n\n

MAPS public\u0113 rezult\u0101tus no pirm\u0101 p\u0113t\u012bjuma par LSD terapeitisko izmanto\u0161anu vair\u0101k nek\u0101 40 gadu laik\u0101., MAPS no Kolor\u0101do \u0161tata sa\u0146em $2 miljonu dot\u0101ciju marihu\u0101nas p\u0113t\u012bjumiem. Tiek dibin\u0101ta MAPS sabiedrisk\u0101 labuma korpor\u0101cija (MAPS PBC)<\/em>.<\/p>\n\n\n\n

2015<\/em><\/h3>\n\n\n\n

MAPS izveido MDMA terapijas m\u0101c\u012bbu programma<\/em> apm\u0101c\u012bt jauno psihed\u0113lisko terapeitu paaudzi. Interneta vietne Reddit d\u0101vina $82,765.95 MAPS starp cit\u0101m bezpe\u013c\u0146as organiz\u0101cij\u0101m, ko izv\u0113l\u0113jusies Reddit kopiena.<\/p>\n\n\n\n

2016<\/em><\/h3>\n\n\n\n

MAPS uzs\u0101ka p\u0113t\u012bjumu par kognit\u012bvi uzved\u012bbas terapiju. (CBCT) <\/em>ar integr\u0113tu MDMA asist\u0113ta terapija PTSD p\u0101riem<\/a>Ar glob\u0101lo psihod\u0113lisko vakari\u0146u pal\u012bdz\u012bbu MAPS kopiena ziedojumos sav\u0101c vair\u0101k nek\u0101 $140 000. Kopum\u0101 to ir 80. <\/p>\n\n\n\n

2017<\/em><\/h3>\n\n\n\n

FDA pie\u0161\u0137ir MDMA statusu izr\u0101viena terapijas l\u012bdzeklim PTSS \u0101rst\u0113\u0161anai. MAPS public\u0113 iboga\u012bna p\u0113t\u012bjumu rezult\u0101tus par opi\u0101tu atkar\u012bbas \u0101rst\u0113\u0161anu. Dr. Bronner's sola MAPS pie\u0161\u0137irt $5 miljonus. 3 000 cilv\u0113ku piedal\u012bj\u0101s Psihod\u0113lisk\u0101 zin\u0101tne 2017<\/em>.<\/p>\n\n\n\n

2018<\/em><\/h3>\n\n\n\n

MAPS ieg\u016bst $8 miljonus, pabeidzot Pineapple Fund $4 miljonu atbilsto\u0161o dot\u0101ciju. K\u0101 main\u012bt pr\u0101tu,<\/em> Maikla Pollana gr\u0101mata, kur\u0101 izcelti MAPS p\u0113t\u012bjumi un psihed\u0113liju zin\u0101tne iepaz\u012bstin\u0101ta pla\u0161\u0101kai auditorijai. <\/p>\n\n\n\n

2019<\/em><\/h3>\n\n\n\n

Doktors Doblins sniedz pirmo ofici\u0101lo TED lekciju par psihed\u0113liskiem l\u012bdzek\u013ciem. MAPS public\u0113 rezult\u0101tus, kas ieg\u016bti, veicot p\u0113d\u0113jo gadu laik\u0101 veikto se\u0161u MDMA terapijas ar PTSD pal\u012bdz\u012bbu 2. f\u0101zes p\u0113t\u012bjumu apvienoto anal\u012bzi.<\/p>\n\n\n\n

2020<\/em><\/h3>\n\n\n\n

FDA pie\u0161\u0137ir papla\u0161in\u0101tas pieejam\u012bbas programmu MDMA terapijai PTSS \u0101rst\u0113\u0161anai. MAPS ziedot\u0101ju kampa\u0146a Capstone Campaign sav\u0101c $30 miljonus psihod\u0113lisko vielu p\u0113tniec\u012bbai. Tiek public\u0113ti pozit\u012bvi MAPS pirm\u0101 3. f\u0101zes p\u0113t\u012bjuma rezult\u0101ti. <\/p>\n\n\n\n

2021<\/em><\/h3>\n\n\n\n

\u0160ogad MAPS public\u0113s visus rezult\u0101tus no pirm\u0101 3. f\u0101zes kl\u012bnisk\u0101 p\u0113t\u012bjuma par MDMA asist\u0113tu terapiju PTSS \u0101rst\u0113\u0161anai. T\u0101 ar\u012b uzs\u0101ks jaunu dal\u012bbas programmu ziedot\u0101jiem. Un vi\u0146i svin\u0113s 35 gadu jubileju par revolucion\u0101riem p\u0113t\u012bjumiem! <\/p>\n\n\n\n

N\u0101kotne ir psihod\u0113liska<\/em><\/h2>\n\n\n\n

L\u016bk, t\u0101tad \u0161eit ir izkl\u0101st\u012bta psihod\u0113lisk\u0101s organiz\u0101cijas v\u0113sture. Un, \u0161\u0137iet, ka viss ir tikai uzplaukum\u0101! Iesp\u0113jams, l\u012bdz br\u012bdim, kad aprit\u0113s MAPS 50. gadadiena, visas t\u0101s apbr\u012bnojam\u0101s lietas, par kur\u0101m vi\u0146i ir c\u012bn\u012bju\u0161ies, b\u016bs sasniegtas. K\u0101 par vi\u0146u pl\u0101noto psihed\u0113lisko n\u0101kotni saka dibin\u0101t\u0101js Riks Doblins; <\/p>\n\n\n\n

\"Es ar\u012b dom\u0101ju, ka m\u0113s virz\u012bsimies uz pasauli p\u0113c aizlieguma... Cilv\u0113ki v\u0113l\u0113sies izbaud\u012bt da\u017e\u0101das \u0161\u012bs vielas person\u012bbas izaugsmei, gar\u012bgumam - ne tikai slim\u012bbai... m\u0113s b\u016bsim sasniegu\u0161i to, ko 60. gadu hipiji naivi dom\u0101ja, ka tas ir tepat aiz st\u016bra. \"<\/em><\/p>\n\n\n\n

Riks, vari m\u016bs pieteikt! <\/strong><\/p>\n\n\n\n

*intervijas fragmenti no pointhistory.com<\/a><\/em><\/p>","protected":false},"excerpt":{"rendered":"

Ja regul\u0101ri las\u0101t m\u016bsu rakstus, noteikti esat paman\u012bju\u0161i, ka m\u0113s bie\u017ei (godbij\u012bgi) pieminam MAPS.<\/p>","protected":false},"author":1,"featured_media":17718,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[69],"tags":[],"topics":[],"class_list":["post-17713","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-psychedelic-culture"],"_links":{"self":[{"href":"https:\/\/staging.wholecelium.com\/lv\/wp-json\/wp\/v2\/posts\/17713","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staging.wholecelium.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging.wholecelium.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging.wholecelium.com\/lv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.wholecelium.com\/lv\/wp-json\/wp\/v2\/comments?post=17713"}],"version-history":[{"count":1,"href":"https:\/\/staging.wholecelium.com\/lv\/wp-json\/wp\/v2\/posts\/17713\/revisions"}],"predecessor-version":[{"id":123674,"href":"https:\/\/staging.wholecelium.com\/lv\/wp-json\/wp\/v2\/posts\/17713\/revisions\/123674"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staging.wholecelium.com\/lv\/wp-json\/wp\/v2\/media\/17718"}],"wp:attachment":[{"href":"https:\/\/staging.wholecelium.com\/lv\/wp-json\/wp\/v2\/media?parent=17713"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.wholecelium.com\/lv\/wp-json\/wp\/v2\/categories?post=17713"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging.wholecelium.com\/lv\/wp-json\/wp\/v2\/tags?post=17713"},{"taxonomy":"topics","embeddable":true,"href":"https:\/\/staging.wholecelium.com\/lv\/wp-json\/wp\/v2\/topics?post=17713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}